Is this you? Create Your Porfile
Avatar

Joan Dawes

The Heart Research Institute

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Joan Dawes is active.

Explore More

Publication

Featured researches published by Joan Dawes.

Thrombosis and Haemostasis | 1989

The absorption, clearance and metabolic fate of dermatan sulphate administered to man- studies using a radioiodinated derivative

Joan Dawes; Hodson Ba; Duncan S. Pepper

Thrombosis and Haemostasis | 1997

Production method affects the pharmacokinetic and ex vivo biological properties of low molecular weight heparins.

David Brieger; Joan Dawes

Thrombosis and Haemostasis | 1993

Interaction of immobilised unfractionated and LMW heparins with proteins in whole human plasma

Adrian Zammit; Duncan S. Pepper; Joan Dawes

Thrombosis and Haemostasis | 1992

Human vascular endothelial cells catabolise exogenous glycosaminoglycans by a novel route.

Joan Dawes; Duncan S. Pepper

Thrombosis and Haemostasis | 1996

Long term persistence of biological activity following administration of enoxaparin sodium (Clexane) is due to sequestration of antithrombin-binding low molecular weight fragments : Comparison with unfractionated heparin

David Brieger; Joan Dawes

Thrombosis and Haemostasis | 1994

Characterisation of persistent anti-Xa activity following administration of the low molecular weight heparin enoxaparin sodium (Clexane).

David Brieger; Joan Dawes

Thrombosis and Haemostasis | 1994

LOW-AFFINITY MATERIAL DOES NOT CONTRIBUTE TO THE ANTITHROMBOTIC ACTIVITY OF ORGARAN (ORG 10172) IN HUMAN PLASMA

Adrian Zammit; Joan Dawes

Thrombosis and Haemostasis | 1993

The pharmacokinetics of LMW dermatan sulphate : long-term persistence of intact material

Joan Dawes

Thrombosis and Haemostasis | 1994

MALFORMIN A PREVENTS IL-1 INDUCED ENDOTHELIAL CHANGES BY INHIBITION OF PROTEIN SYNTHESIS

Bannon Pg; Joan Dawes; Roger T. Dean

Thrombosis and Haemostasis | 1996

Low molecular weight heparin is responsible for the anti-Xa activity of Desmin 370.

David Brieger; Joan Dawes

Explore More

Collaboration

Dive into the Joan Dawes's collaboration.

Top Co-Authors
Avatar

David Brieger

The Heart Research Institute

View shared research outputs
Top Co-Authors
Avatar

Duncan S. Pepper

Scottish National Blood Transfusion Service

View shared research outputs
Top Co-Authors
Avatar

Adrian Zammit

The Heart Research Institute

View shared research outputs
Top Co-Authors
Avatar

Bannon Pg

The Heart Research Institute

View shared research outputs
Top Co-Authors
Avatar

Roger T. Dean

University of Western Sydney

View shared research outputs
Top Co-Authors
Avatar

Xanthe Wells

The Heart Research Institute

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge